Misonix (MSON) Reports Q4 EPS of $0.46

Go back to Misonix (MSON) Reports Q4 EPS of $0.46

Misonix, Inc. Announces Fourth Quarter and Fiscal Year End 2015 Financial Results

August 20, 2015 4:01 PM EDT

FARMINGDALE, N.Y., Aug. 20, 2015 /PRNewswire/ -- Misonix, Inc. (NASDAQ: MSON), an international surgical device company that designs, manufactures and markets innovative therapeutic ultrasonic products for spine surgery, skull based surgery, neurosurgery, wound and burn debridement, cosmetic surgery, laparoscopic surgery and other surgical applications, today announced financial results for the fourth quarter and full year fiscal 2015 ended June 30, 2015.

Highlights for the fourth quarter and full year fiscal 2015 included:

Net sales for the fourth quarter fiscal 2015 were $6.7 million, a 21% increase, compared to $5.6 million for the same period in fiscal 2014.... More